Roth Capital Downgrades Gemphire Therapeutics (GEMP) to Neutral Citing Lack of Catalysts Aug 10, 2018 09:38AM
Gemphire Therapeutics (GEMP) PT Raised to $40 at Roth Capital (pre-market) Jul 27, 2018 09:42AM
Gemphire Therapeutics (GEMP) Prices 3.14M Common Stock Offering at $7/Share Feb 8, 2018 09:04AM
Gemphire Announces Pricing of $22 Million Public Offering of Common Stock Feb 8, 2018 09:00AM
Roth Capital Starts Gemphire Therapeutics (GEMP) at Buy Oct 19, 2017 07:27AM


Apr 18, 2016 05:23PM Gemphire Therapeutics (GEMP) Files $60M IPO